GO:1904036 negative regulation of epithelial cell apoptotic process: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:1904036 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of apoptosis specifically in epithelial cells.
This regulatory process is essential for epithelial tissue homeostasis, wound healing, and the prevention of fibrosis and cancer.
Key molecular players include anti-apoptotic proteins, microRNAs, circular RNAs, and metabolic regulators such as CD47 and NNMT.
Dysregulation of this process contributes to inflammatory bowel disease, renal fibrosis, prostate regression disorders, and tumorigenesis.
CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect the causal roles of specific genes in this pathway.
Understanding GO:1904036 provides a framework for developing therapies that modulate epithelial cell survival in disease contexts.

Description

Epithelial cells form the protective barriers of the body and are subject to tight regulation of their lifespan. The Gene Ontology term GO:1904036, negative regulation of epithelial cell apoptotic process, encompasses all molecular events that inhibit programmed cell death in these cells. This process is critical for normal development, tissue repair, and immune defense, but its dysregulation underlies numerous pathologies including fibrosis, chronic inflammation, and cancer. Researchers studying epithelial biology need a clear understanding of the mechanisms that suppress apoptosis, as these pathways are frequently hijacked in disease. Recent studies have identified diverse regulators, from circular RNAs to metabolic enzymes, that modulate epithelial cell survival. This article synthesizes current knowledge on GO:1904036, highlighting its molecular basis, key genes, disease relevance, and the CRISPR-based methods used to investigate it.

negative regulation of epithelial cell apoptotic process At A Glance

GO ID GO:1904036
GO term negative regulation of epithelial cell apoptotic process
Ontology biological_process
Synonym inhibition of epithelial cell apoptosis; downregulation of epithelial cell apoptotic process; negative regulation of epitheliocyte apoptosis
Major function Suppression of programmed cell death in epithelial cells to maintain tissue integrity and homeostasis
Related processes Apoptotic signaling, cell survival, epithelial regeneration, inflammation resolution
Disease relevance Fibrosis, inflammatory bowel disease, cancer, prostate regression disorders
Research tools CRISPR knockout/knock-in, overexpression, RNA interference, flow cytometry

What Is GO:1904036?

GO:1904036 is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of the apoptotic process in epithelial cells. This includes both direct inhibition of apoptotic signaling and indirect mechanisms that promote cell survival, such as enhancing anti-apoptotic protein expression or blocking pro-apoptotic factors.

Why Is negative regulation of epithelial cell apoptotic process Important in Cell Biology?

GO:1904036 is fundamental to epithelial tissue homeostasis and repair. By preventing inappropriate apoptosis, it ensures barrier integrity and promotes regeneration after injury. Conversely, excessive inhibition of epithelial apoptosis can lead to fibrosis or cancer, while insufficient inhibition contributes to degenerative conditions. Thus, understanding this process is essential for developing targeted therapies across a spectrum of diseases.
Maintains epithelial barrier function by preventing cell loss.
Promotes wound healing and tissue regeneration after injury.
Prevents fibrosis by limiting maladaptive repair responses.
Supports immune homeostasis in the gut by protecting intestinal epithelial cells.
Contributes to prostate regression by regulating cell survival during androgen deprivation.
Dysregulation is linked to inflammatory bowel disease and colitis.
Implicated in renal fibrosis and chronic kidney disease.
Plays a role in cancer development by allowing epithelial cells to evade apoptosis.
Serves as a target for therapeutic intervention in fibrotic and inflammatory diseases.
Provides a model for studying cell death regulation in epithelial tissues.

What Happens During negative regulation of epithelial cell apoptotic process?

Initiation of Survival Signaling
In simple terms: Cells receive signals that tell them to stay alive.
Negative regulation of epithelial cell apoptosis often begins with extracellular survival factors or intracellular stress responses that activate pro-survival pathways. For example, circular RNA circBNC2 inhibits epithelial cell G2-M arrest and prevents fibrotic maladaptive repair, thereby promoting survival. Similarly, CD47 acts as a negative regulator of intestinal epithelial cell self-renewal following DSS-induced colitis, suggesting a role in survival signaling.
Inhibition of Pro-apoptotic Factors
In simple terms: The cell blocks the proteins that would normally cause it to die.
A key step is the suppression of pro-apoptotic proteins such as BAX, BAK, or caspases. In renal tubular epithelial cells, CircAASS alleviates injury and fibrosis by regulating mitochondrial homeostasis, which involves inhibiting apoptosis. Additionally, PI(4,5)P2 alleviates colitis by inhibiting intestinal epithelial cell pyroptosis through NNMT-mediated RBP4 m6A modification, indicating cross-talk between apoptotic and pyroptotic regulation.
Mitochondrial Homeostasis and Metabolic Control
In simple terms: The cell's powerhouses are kept healthy to prevent death signals.
Mitochondrial integrity is crucial for preventing apoptosis. CircAASS regulates mitochondrial homeostasis in tubular epithelial cells, thereby reducing apoptosis and fibrosis. Metabolic enzymes like NNMT modulate RNA methylation to influence cell survival, linking metabolism to apoptotic regulation.
Clearance of Apoptotic Cells and Reprogramming
In simple terms: When some cells die, their removal can trigger survival and reprogramming in neighbors.
Apoptotic cell clearance triggers epithelial fate reprogramming during prostate regression, a process that involves negative regulation of apoptosis to maintain tissue architecture. This highlights how the clearance of dying cells can actively promote survival and reprogramming in remaining epithelial cells.
Regulation of Exfoliation and Cell Number
In simple terms: The body controls how many cells are shed to keep the right number.
In the mammary gland, regulation of cell number is achieved by controlling the exfoliation process in milk, which involves negative regulation of apoptosis to balance cell loss and survival. This demonstrates the importance of this process in normal physiology.

Key Genes Involved in GO:1904036 negative regulation of epithelial cell apoptotic process

The following genes and non-coding RNAs have been experimentally implicated in the negative regulation of epithelial cell apoptotic process.
GeneMajor RoleResearch Relevance
circBNC2Inhibits epithelial cell G2-M arrest to prevent fibrotic maladaptive repairCircular RNA; potential therapeutic target for fibrosis
CircAASSRegulates mitochondrial homeostasis in tubular epithelial cellsAlleviates renal injury and fibrosis
CD47Negative regulator of intestinal epithelial cell self-renewalModulates colitis recovery
NNMTMediates RBP4 m6A modification to inhibit pyroptosisMetabolic enzyme; target for colitis
Galectin-7Pro-apoptotic in some contexts, but may have anti-apoptotic rolesInvolved in epithelial cell survival
NSP5SARS-CoV-2 protein that modulates inflammatory cell deathViral regulation of apoptosis
ORF6SARS-CoV-2 protein that modulates inflammatory cell deathViral regulation of apoptosis
NSP13SARS-CoV-2 protein that modulates inflammatory cell deathViral regulation of apoptosis
RBP4Regulated by NNMT-mediated m6A modificationInvolved in colitis and epithelial survival
BAXPro-apoptotic factor, indirectly regulatedDownstream target of survival pathways
BAKPro-apoptotic factor, indirectly regulatedDownstream target of survival pathways
Caspase-3Executioner caspase, inhibited in survivalMarker of apoptosis
Caspase-8Initiator caspase, inhibited in survivalMarker of apoptosis
Bcl-2Anti-apoptotic protein, often upregulatedPromotes epithelial survival
Bcl-xLAnti-apoptotic protein, often upregulatedPromotes epithelial survival
Mcl-1Anti-apoptotic protein, often upregulatedPromotes epithelial survival
XIAPInhibitor of apoptosis proteinBlocks caspase activity
SurvivinInhibitor of apoptosis proteinPromotes cell division and survival

How Is negative regulation of epithelial cell apoptotic process Regulated?

The negative regulation of epithelial cell apoptotic process is controlled by a complex network of signaling pathways. Circular RNAs such as circBNC2 and CircAASS act as sponges for microRNAs or interact with proteins to modulate survival. Metabolic enzymes like NNMT influence RNA methylation, affecting the stability of transcripts encoding pro-survival factors. Viral proteins from SARS-CoV-2 (NSP5, ORF6, NSP13) can modulate inflammatory cell death, highlighting pathogen-driven regulation. Additionally, cell surface receptors like CD47 transmit survival signals in intestinal epithelium. These diverse mechanisms converge on the core apoptotic machinery to tip the balance toward cell survival.

negative regulation of epithelial cell apoptotic process and Human Disease

GeneDisease / BiologyPotential Experimental Model
circBNC2Renal fibrosis, maladaptive repairKnockout and overexpression in tubular epithelial cells
CircAASSRenal injury and fibrosisKnockout and overexpression in renal epithelial cells
CD47Colitis, intestinal barrier dysfunctionKnockout mice and intestinal organoids
NNMTColitis, pyroptosisKnockout and overexpression in intestinal epithelial cells
Galectin-7Cancer, epithelial survivalKnockout and overexpression in cancer cell lines
Fibrosis and Chronic Kidney Disease
Maladaptive repair after injury often leads to fibrosis, a process driven by epithelial cell apoptosis and subsequent fibrotic remodeling. CircBNC2 inhibits epithelial cell G2-M arrest to prevent fibrotic maladaptive repair, suggesting that enhancing its function could mitigate fibrosis. Similarly, CircAASS alleviates renal injury and fibrosis by regulating mitochondrial homeostasis in tubular epithelial cells, reducing apoptosis. These findings position negative regulation of epithelial apoptosis as a therapeutic target in chronic kidney disease.
Inflammatory Bowel Disease and Colitis
Intestinal epithelial cell apoptosis contributes to barrier dysfunction in inflammatory bowel disease. CD47 acts as a negative regulator of intestinal epithelial cell self-renewal following DSS-induced colitis, indicating that CD47-mediated survival signaling is protective. PI(4,5)P2 alleviates colitis by inhibiting intestinal epithelial cell pyroptosis through NNMT-mediated RBP4 m6A modification, linking lipid signaling and RNA methylation to epithelial survival. Thus, strategies to boost negative regulation of apoptosis may benefit colitis patients.
Prostate Regression and Cancer
During prostate regression, apoptotic cell clearance triggers epithelial fate reprogramming, a process that requires tight regulation of apoptosis. Dysregulation of this process can contribute to prostate cancer, where epithelial cells evade apoptosis. Galectin-7, a protein involved in epithelial cell survival, may play a role in cancer progression. Understanding how negative regulation of apoptosis is subverted in cancer could reveal new therapeutic targets.
Viral Infections and Inflammatory Cell Death
SARS-CoV-2 proteins NSP5, ORF6, and NSP13 cooperate to modulate inflammatory cell death, including apoptosis, in epithelial cells. This modulation may contribute to viral pathogenesis and tissue damage. Studying how these viral factors intersect with host negative regulation of apoptosis could inform antiviral strategies.

From negative regulation of epithelial cell apoptotic process-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X inhibit epithelial apoptosis?CRISPR knockout in epithelial cell lines (e.g., HEK293T, Caco-2)
Does a point mutation in gene X affect its anti-apoptotic function?CRISPR point mutation knock-in in epithelial cells
Does overexpression of gene X protect against apoptosis?CRISPR activation or lentiviral overexpression
Does a tagged version of gene X localize to specific organelles?CRISPR knock-in of fluorescent tag
Does gene X regulate apoptosis in vivo?Conditional knockout mouse models
Can we screen for novel regulators of epithelial apoptosis?CRISPR library screening in epithelial cells

How to Study the negative regulation of epithelial cell apoptotic process Process

MethodWhat It MeasuresTypical Application
Flow cytometry (Annexin V/PI)Apoptotic cell percentageQuantify apoptosis after gene knockout
Western blotCleaved caspase-3, PARP, Bcl-2Validate apoptosis regulation
ImmunofluorescenceMitochondrial integrity, cytochrome cAssess mitochondrial apoptosis
RNA-seqGlobal transcriptome changesIdentify pathways and non-coding RNAs
CRISPR library screeningEnrichment of sgRNAsDiscover novel regulators
qRT-PCRmRNA expression of target genesConfirm knockout/overexpression
Co-immunoprecipitationProtein-protein interactionsStudy survival complexes
Organoid cultureEpithelial survival in 3DModel tissue-specific apoptosis
Flow Cytometry and Annexin V Staining
Flow cytometry with Annexin V and propidium iodide is a standard method to quantify apoptosis in epithelial cells. It measures phosphatidylserine externalization, an early apoptotic marker. This method is widely used to assess the effect of gene knockouts or overexpression on epithelial cell survival.
Western Blot and Immunofluorescence
Western blotting for cleaved caspase-3, PARP, and Bcl-2 family proteins provides biochemical evidence of apoptosis regulation. Immunofluorescence can visualize mitochondrial integrity and cytochrome c release. These techniques are essential for validating findings from CRISPR screens.
RNA Sequencing and Bioinformatics
RNA-seq allows global transcriptomic analysis to identify pathways altered upon manipulation of candidate genes. Bioinformatics tools can uncover circular RNAs, microRNAs, and m6A modifications involved in negative regulation of apoptosis.
CRISPR Library Screening
Genome-wide CRISPR knockout or activation screens can identify novel regulators of epithelial apoptosis. Cells are subjected to apoptotic stimuli, and surviving cells are sequenced to identify enriched sgRNAs. This unbiased approach has revealed key players like circBNC2 and NNMT.

How CRISPR Can Be Used to Study GO:1904036 negative regulation of epithelial cell apoptotic process

Knockout

CRISPR knockout is used to delete candidate genes and assess whether their loss increases epithelial apoptosis. For example, knocking out CD47 in intestinal epithelial cells can reveal its role in self-renewal and survival. Similarly, knockout of NNMT can test its requirement for inhibiting pyroptosis.

Point Mutation

Point mutation knock-in allows researchers to study specific amino acid residues critical for anti-apoptotic function. For instance, mutating phosphorylation sites in Bcl-2 family proteins can determine their role in survival signaling. This approach provides mechanistic insights beyond simple knockout.

Knock-in

Knock-in of fluorescent tags or epitope tags enables visualization and biochemical analysis of endogenous proteins. Tagging CircAASS or circBNC2 with a fluorescent reporter can track their localization and interaction partners in epithelial cells.

Overexpression

CRISPR activation (CRISPRa) or lentiviral overexpression is used to test whether increasing a gene's expression protects epithelial cells from apoptosis. Overexpressing circBNC2 or CircAASS has been shown to reduce apoptosis and fibrosis in models. This approach is valuable for validating therapeutic targets.

How EDITGENE Supports negative regulation of epithelial cell apoptotic process Research

Researchers studying negative regulation of epithelial cell apoptotic process-related genes often need to determine whether a candidate gene is causally involved in cell survival or merely a bystander. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of epithelial cell apoptotic process research.

Frequently Asked Questions About negative regulation of epithelial cell apoptotic process

GO:1904036 is the Gene Ontology term for negative regulation of epithelial cell apoptotic process, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of apoptosis in epithelial cells.
Key genes include circBNC2, CircAASS, CD47, NNMT, and viral proteins such as NSP5, ORF6, and NSP13, as well as anti-apoptotic Bcl-2 family members.
It is regulated by a balance of pro-apoptotic and anti-apoptotic signals, including circular RNAs, metabolic enzymes, cell surface receptors, and mitochondrial homeostasis pathways.
Dysregulation is linked to fibrosis, inflammatory bowel disease, colitis, prostate regression disorders, and cancer.
Common methods include flow cytometry, Western blot, RNA-seq, CRISPR knockout/knock-in, and CRISPR library screening.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in epithelial apoptosis.
Circular RNAs such as circBNC2 and CircAASS can inhibit apoptosis by regulating cell cycle arrest, mitochondrial homeostasis, and fibrosis.
CD47 acts as a negative regulator of intestinal epithelial cell self-renewal following DSS-induced colitis, promoting survival.
NNMT mediates RBP4 m6A modification to inhibit intestinal epithelial cell pyroptosis, a form of inflammatory cell death.
Cancer cells often evade apoptosis; understanding this process can reveal targets to induce cell death in tumors.

Conclusion

GO:1904036, negative regulation of epithelial cell apoptotic process, is a critical biological process that maintains epithelial tissue homeostasis and prevents disease. Research has uncovered diverse molecular players, from circular RNAs to metabolic enzymes, that suppress apoptosis in epithelial cells. Dysregulation of this process contributes to fibrosis, inflammatory bowel disease, and cancer, making it a promising therapeutic target. CRISPR-based models are indispensable for dissecting the causal roles of specific genes and for developing new interventions. EDITGENE offers comprehensive services to support these studies, from knockout to library screening, empowering researchers to advance the field.

References

  1. 1. Saussez S et al.. 2006. Galectin-7.. Cell Mol Life Sci 63(6):686-97 PMID: 16429325
  2. 2. Wang P et al.. 2022. Circular RNA circBNC2 inhibits epithelial cell G2-M arrest to prevent fibrotic maladaptive repair.. Nat Commun 13(1):6502 PMID: 36316334
  3. 3. Wang H et al.. 2025. The NSP5, ORF6 and NSP13 of SARS-CoV-2 Cooperate to Modulate Inflammatory Cell Death Activation.. Adv Sci (Weinh) 12(41):e03977 PMID: 40810650
  4. 4. Ma T et al.. 2026. CircAASS alleviates renal injury and fibrosis by regulating mitochondrial homeostasis in tubular epithelial cells.. Autophagy 22(1):182-206 PMID: 41162865
  5. 5. Herve L et al.. 2016. Regulation of cell number in the mammary gland by controlling the exfoliation process in milk in ruminants.. J Dairy Sci 99(1):854-63 PMID: 26433413
  6. 6. Graham-Paquin AL et al.. 2026. Apoptotic cell clearance triggers epithelial fate reprogramming during prostate regression.. Cell Death Dis 17(1) PMID: 41963285
  7. 7. He Y et al.. 2020. CD47 is a negative regulator of intestinal epithelial cell self-renewal following DSS-induced experimental colitis.. Sci Rep 10(1):10180 PMID: 32576895
  8. 8. Yang Q et al.. 2024. PI(4,5)P2 alleviates colitis by inhibiting intestinal epithelial cell pyroptosis through NNMT-mediated RBP4 m6A modification.. Cell Death Dis 15(12):923 PMID: 39706833
Contact Us
*
*
*
*
How did you hear about us: